Drug Description in Trials / DrugBank / KEGG DRUG /


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-[1] Pyrazole---[1] 75
2(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE[1] Pyrazole---[1] 75
3(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE[1] Pyrazole---[1] 75
417beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one----[1] 75
517ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one----[1] 75
618F-DOPA----[2] 6, 75
71H-Pyrazol[1] Pyrazole---[5] 2, 28, 46, 75, 154
82S,4R-(-)-ketoconazole[1] Ketoconazole[1] D00351 [1] CYP17A1 💬[6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬[1] 75
92S,4R-(-)-ketoconazole, levoketoconazole[2] Ketoconazole,
Levoketoconazole
[2] D00351 ,
D10950
[1] CYP17A1 💬[6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬[1] 75
1068Ga-DOTATATE[2] Dotatate,
Dotatate gallium Ga-68
---[3] 75, 84, 238
11Abiraterone[1] Abiraterone---[2] 75, 81
12Abiraterone Acetate[2] Abiraterone,
Acetate
---[2] 75, 81
13Abiraterone acetato[1] Abiraterone---[1] 75
14Acetate[1] Acetate---[43] 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299
15Acthrel[1] Corticorelin ovine triflutate[1] D03592 [2] CRHR1,
CRHR2 💬
[4] Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
16Alprazolam[1] Alprazolam[1] D00225 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[2] 8, 75
17ATR-101----[2] 75, 81
18AZD4017----[1] 75
19AZD4017 and prednisolone[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 75
20Bexarotene[1] Bexarotene[1] D03106 [3] RXRA,
RXRB,
RXRG 💬
[17] Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬[2] 13, 75
21CABERGOLINA[1] Cabergoline[1] D00987 [2] DRD2,
PRL 💬
[12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 6, 75
22Cabergoline[1] Cabergoline[1] D00987 [2] DRD2,
PRL 💬
[12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 6, 74, 75
23CABERGOLINE TEVA[1] Cabergoline[1] D00987 [2] DRD2,
PRL 💬
[12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 75
24Calcium[1] Calcium---[30] 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299
25Calcium carbonate[3] Calcium,
Calcium carbonate,
Carbonate ion
[2] D00932 ,
D10802
--[8] 13, 19, 46, 53, 75, 96, 235, 299
26Carbonate[1] Carbonate ion---[12] 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299
27CHOLECALCIFEROL[1] Cholecalciferol[1] D00188 [1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[10] 13, 19, 34, 46, 49, 75, 96, 97, 298, 299
28Cholecalciferol 15000 UNT/ML Oral Solution[1] Cholecalciferol[1] D00188 [1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 75
29CI-984----[1] 75
30CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE[1] Tadalafil[1] D02008 [1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[1] 75
31Continuous glucose monitoring[1] Dextrose, unspecified form---[2] 75, 299
32COR-003----[1] 75
33CORT125134[1] Relacorilant[1] D11336 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 75
34Corticotropin[1] Corticotropin[1] D00146 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[9] 2, 13, 46, 75, 78, 81, 84, 205, 222
35Corticotropin-releasing hormone[2] Corticorelin,
Corticotropin
[2] D00146 ,
D03905
[3] CRHR1,
CRHR2,
MC2R 💬
[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 75, 205
36Cushing's syndrome confirmation----[1] 75
37Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly di-aspartate[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
38Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly di-aspartate[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
39Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) di-aspartate[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
40Cyclo(diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe)[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
41DDAVP[1] Desmopressin[2] D00291 ,
D02235
[2] AVPR2,
F8 💬
[4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[2] 75, 288
42Dexamethasone[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
43Diagnostic Test: 24-hour Urine test----[1] 75
44Diagnostic Test: Blood test----[1] 75
45Diagnostic Test: Dexamethasone test[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 75
46Diagnostic Test: Gated MRI scan----[1] 75
47Diagnostic Test: Routine MRI scan----[1] 75
48Diagnostic Test: Saliva swab----[1] 75
49DOSTINEX[1] Cabergoline[1] D00987 [2] DRD2,
PRL 💬
[12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 75
50Dotatate[1] Dotatate---[4] 41, 75, 84, 238
51Eplerenone[1] Eplerenone[1] D01115 [1] NR3C2 💬[1] Aldosterone-regulated sodium reabsorption 💬[4] 75, 113, 210, 215
52G02CB03----[1] 75
53Gefitinib[1] Gefitinib[1] D01977 [1] EGFR 💬[48] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬[1] 75
54Genotropin 12mg[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 74, 75, 78
55Genotropin 5.3mg[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 74, 75, 78
56Genotropin Miniqu[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 74, 75, 78
57Genotropin Miniquick 0.2mg[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 74, 75, 78
58Genotropin Miniquick 0.4mg[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 74, 75, 78
59Genotropin Miniquick 0.6mg[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 74, 75, 78
60Genotropin Miniquick 0.8mg[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 74, 75, 78
61Genotropin Miniquick 1.0mg[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 74, 75, 78
62Genotropin Miniquick 1.2mg[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 74, 75, 78
63Glucocorticoids----[8] 40, 41, 43, 44, 60, 62, 75, 300
64Glucophage (metformin)[1] Metformin[2] D00944 ,
D04966
[2] PRKAA1,
PRKAA2 💬
[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[2] 46, 75
65Glucose[1] Dextrose, unspecified form---[15] 2, 6, 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299
66HRA052015----[1] 75
67HRA052015 (mifepristone)[1] Mifepristone[1] D00585 [2] NR3C1,
PGR 💬
[6] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 75
68Hydrocortisone[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[10] 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
69Hypercortisolism----[1] 75
70Hypro----[1] 75
71Insulin----[6] 6, 13, 46, 75, 78, 299
72IPC----[1] 75
73Ketoconazole[1] Ketoconazole[1] D00351 [1] CYP17A1 💬[6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬[3] 8, 13, 75
74L0006CP03A----[1] 75
75L01XX14----[1] 75
76LA----[5] 6, 13, 75, 76, 222
77Lapatinib[1] Lapatinib[2] D04024 ,
D08108
[2] EGFR,
ERBB2 💬
[50] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction 💬[3] 34, 74, 75
78Lateral transperitoneal LA----[1] 75
79LCI699----[1] 75
80LCI699, 1 mg----[1] 75
81LCI699, 10 mg----[1] 75
82LCI699, 20 mg----[1] 75
83LCI699, 5 mg----[1] 75
84Levoketoconazole[1] Levoketoconazole[1] D10950 --[1] 75
85Levoketozonazole----[1] 75
86Liqourice----[1] 75
87Liraglutide[1] Liraglutide[1] D06404 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 6, 75, 193
88LMWH/Rivaroxaban[1] Rivaroxaban[1] D07086 [1] F10 💬[1] Complement and coagulation cascades 💬[1] 75
89Matyrapone----[1] 75
90Metformin[1] Metformin[2] D00944 ,
D04966
[2] PRKAA1,
PRKAA2 💬
[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[24] 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
91Methionine[1] Methionine[2] D00019 ,
D04983
--[7] 34, 75, 84, 93, 229, 298, 300
92Metopirone[1] Metyrapone[2] D00410 ,
D05019
[1] CYP11B1 💬[4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬[1] 75
93Metopirone 250 mg capsules[1] Metyrapone[2] D00410 ,
D05019
[1] CYP11B1 💬[4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬[1] 75
94Metopirone 250 mg capsules/ Cormeto[1] Metyrapone[2] D00410 ,
D05019
[1] CYP11B1 💬[4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬[1] 75
95Metopirone 250 mg capsules/Cormeto[1] Metyrapone[2] D00410 ,
D05019
[1] CYP11B1 💬[4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬[1] 75
96METYRAPONE[1] Metyrapone[2] D00410 ,
D05019
[1] CYP11B1 💬[4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬[2] 75, 193
97Mifedren----[1] 75
98MIFEPRISTONE[1] Mifepristone[1] D00585 [2] NR3C1,
PGR 💬
[6] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 75
99Nevanimibe[1] Nevanimibe[1] D11300 --[2] 75, 81
100Nevanimibe hydrochloride[1] Nevanimibe[1] D11300 --[2] 75, 81
101NIZORAL[1] Ketoconazole[1] D00351 [1] CYP17A1 💬[6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬[1] 75
102NON COMMERCIAL----[1] 75
103Octreotide[1] Octreotide[2] D00442 ,
D06495
[1] SSTR2 💬[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[7] 67, 75, 84, 85, 89, 193, 227
104OROCAL----[1] 75
105OSILODROSTAT[1] Osilodrostat[1] D11061 [1] CYP11B2 💬[3] Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬[1] 75
106Osilodrostat 10mg[1] Osilodrostat[1] D11061 [1] CYP11B2 💬[3] Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬[1] 75
107Osilodrostat 1mg[1] Osilodrostat[1] D11061 [1] CYP11B2 💬[3] Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬[1] 75
108Osilodrostat 20mg[1] Osilodrostat[1] D11061 [1] CYP11B2 💬[3] Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬[1] 75
109Osilodrostat 5mg[1] Osilodrostat[1] D11061 [1] CYP11B2 💬[3] Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬[1] 75
110Ossein hydroxyapatite----[1] 75
111OSTEOPOR----[1] 75
112Other: [11C]-Methionine PET/MRI[1] Methionine[2] D00019 ,
D04983
--[1] 75
113Other: Control----[9] 6, 19, 67, 70, 75, 85, 97, 162, 193
114Other: Hydrocortisone[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 75
115Other: Obese----[1] 75
116Ovine Corticotropin-Releasing Hormone (oCRH)[2] Corticorelin,
Corticotropin
[2] D00146 ,
D03905
[3] CRHR1,
CRHR2,
MC2R 💬
[6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
117Pasireotida[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
118Pasireotida 300[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
119Pasireotida 600[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
120Pasireotida 900[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
121Pasireotide[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 67, 74, 75
122Pasireotide 0.3mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
123Pasireotide 0.6 MG/ML[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
124Pasireotide 0.6mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
125Pasireotide 0.9 mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
126Pasireotide 20mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
127Pasireotide 40mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
128Pasireotide 60mg[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
129PASIREOTIDE DIASPARTATE[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
130Pasireotide LAR[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 67, 75
131PASIREOTIDE PAMOATE[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
132Pasireotide s.c.[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
133Pasireotide sub-cutaneous[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
134Pasireotide with or without cabergoline[2] Cabergoline,
Pasireotide
[2] D00987 ,
D10147
[6] DRD2,
PRL,
SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 75
135Pasireotode----[1] 75
136Pentetreotide[1] Pentetreotide[1] D01859 --[1] 75
137Phe----[2] 75, 240
138Posterior RA----[1] 75
139PREDNISOLONE[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[43] 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
140R-roscovitine[1] Seliciclib---[1] 75
141Radiation: CT scan----[1] 75
142Radiation: DOTATATE PET-CT[1] Dotatate---[1] 75
143Radiation: F-DOPA PET CT----[1] 75
144Relacorilant[1] Relacorilant[1] D11336 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 75
145Rivaroxaban[1] Rivaroxaban[1] D07086 [1] F10 💬[1] Complement and coagulation cascades 💬[5] 46, 49, 75, 91, 210
146Rosiglitazone[1] Rosiglitazone[2] D00596 ,
D08491
[1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[5] 46, 75, 97, 222, 265
147Rosiglitazone maleate[1] Rosiglitazone[2] D00596 ,
D08491
[1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[3] 46, 75, 265
148RVG 08938----[1] 75
149RVG 15375----[1] 75
150RVG 18236----[2] 75, 227
151Seliciclib[1] Seliciclib---[2] 75, 299
152SIGNIFOR[1] Pasireotide[1] D10147 [4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75
153Silycus----[1] 75
154Sitagliptin[1] Sitagliptin[1] D08516 [1] DPP4 💬[1] Protein digestion and absorption 💬[4] 6, 75, 233, 299
155SOM230----[2] 74, 75
156SOM230 300µg----[1] 75
157SOM230 600µg----[1] 75
158SOM230 900µg----[1] 75
159SOM230 LAR----[1] 75
160SOM230 LAR 10 mg----[1] 75
161SOM230 LAR 30 mg----[1] 75
162SOM230 LAR, 20 mg----[1] 75
163SOM230 s.c.----[1] 75
164SOM230, 300micrograms----[1] 75
165SOM230, 600 micrograms----[1] 75
166SOM230, 900 micrograms----[1] 75
167SOM230B----[1] 75
168Somatropin[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[19] 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299
169Tadalafil[1] Tadalafil[1] D02008 [1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[7] 6, 51, 75, 84, 86, 113, 210
170Tretinoin[1] Tretinoin[1] D00094 [3] PML,
RARA,
RARB 💬
[12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬[3] 2, 62, 75
171TRETINOINA[1] Tretinoin[1] D00094 [3] PML,
RARA,
RARB 💬
[12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬[1] 75
172Trp----[1] 75
173Tyr----[2] 75, 298
174Valsartan[1] Valsartan[1] D00400 [1] AGTR1 💬[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[7] 57, 58, 66, 75, 218, 222, 224
175VESANOID[1] Tretinoin[1] D00094 [3] PML,
RARA,
RARB 💬
[12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬[1] 75
176Vorinostat[1] Vorinostat[1] D06320 [11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬
[17] Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[3] 19, 75, 96
177ZYTIGA[1] Abiraterone---[1] 75
178ZYTIGA - 250 MG - COMPRESSA - USO ORALE - FLACONE 120 COMPRESSE[1] Abiraterone---[1] 75